Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis

Summary: Airway inflammation underlies cystic fibrosis (CF) pulmonary exacerbations. In a prospective multicenter study of randomly selected, clinically stable adolescents and adults, we assessed relationships between 24 inflammation-associated molecules and the future occurrence of CF pulmonary exa...

Full description

Bibliographic Details
Main Authors: Theodore G. Liou, Natalia Argel, Fadi Asfour, Perry S. Brown, Barbara A. Chatfield, David R. Cox, Cori L. Daines, Dixie Durham, Jessica A. Francis, Barbara Glover, My Helms, Theresa Heynekamp, John R. Hoidal, Judy L. Jensen, Christiana Kartsonaki, Ruth Keogh, Carol M. Kopecky, Noah Lechtzin, Yanping Li, Jerimiah Lysinger, Osmara Molina, Craig Nakamura, Kristyn A. Packer, Robert Paine, III, Katie R. Poch, Alexandra L. Quittner, Peggy Radford, Abby J. Redway, Scott D. Sagel, Rhonda D. Szczesniak, Shawna Sprandel, Jennifer L. Taylor-Cousar, Jane B. Vroom, Ryan Yoshikawa, John P. Clancy, J. Stuart Elborn, Kenneth N. Olivier, Frederick R. Adler
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004224000567
_version_ 1827348267429527552
author Theodore G. Liou
Natalia Argel
Fadi Asfour
Perry S. Brown
Barbara A. Chatfield
David R. Cox
Cori L. Daines
Dixie Durham
Jessica A. Francis
Barbara Glover
My Helms
Theresa Heynekamp
John R. Hoidal
Judy L. Jensen
Christiana Kartsonaki
Ruth Keogh
Carol M. Kopecky
Noah Lechtzin
Yanping Li
Jerimiah Lysinger
Osmara Molina
Craig Nakamura
Kristyn A. Packer
Robert Paine, III
Katie R. Poch
Alexandra L. Quittner
Peggy Radford
Abby J. Redway
Scott D. Sagel
Rhonda D. Szczesniak
Shawna Sprandel
Jennifer L. Taylor-Cousar
Jane B. Vroom
Ryan Yoshikawa
John P. Clancy
J. Stuart Elborn
Kenneth N. Olivier
Frederick R. Adler
author_facet Theodore G. Liou
Natalia Argel
Fadi Asfour
Perry S. Brown
Barbara A. Chatfield
David R. Cox
Cori L. Daines
Dixie Durham
Jessica A. Francis
Barbara Glover
My Helms
Theresa Heynekamp
John R. Hoidal
Judy L. Jensen
Christiana Kartsonaki
Ruth Keogh
Carol M. Kopecky
Noah Lechtzin
Yanping Li
Jerimiah Lysinger
Osmara Molina
Craig Nakamura
Kristyn A. Packer
Robert Paine, III
Katie R. Poch
Alexandra L. Quittner
Peggy Radford
Abby J. Redway
Scott D. Sagel
Rhonda D. Szczesniak
Shawna Sprandel
Jennifer L. Taylor-Cousar
Jane B. Vroom
Ryan Yoshikawa
John P. Clancy
J. Stuart Elborn
Kenneth N. Olivier
Frederick R. Adler
author_sort Theodore G. Liou
collection DOAJ
description Summary: Airway inflammation underlies cystic fibrosis (CF) pulmonary exacerbations. In a prospective multicenter study of randomly selected, clinically stable adolescents and adults, we assessed relationships between 24 inflammation-associated molecules and the future occurrence of CF pulmonary exacerbation using proportional hazards models. We explored relationships for potential confounding or mediation by clinical factors and assessed sensitivities to treatments including CF transmembrane regulator (CFTR) protein synthesis modulators. Results from 114 participants, including seven on ivacaftor or lumacaftor-ivacaftor, representative of the US CF population during the study period, identified 10 biomarkers associated with future exacerbations mediated by percent predicted forced expiratory volume in 1 s. The findings were not sensitive to anti-inflammatory, antibiotic, and CFTR modulator treatments. The analyses suggest that combination treatments addressing RAGE-axis inflammation, protease-mediated injury, and oxidative stress might prevent pulmonary exacerbations. Our work may apply to other airway inflammatory diseases such as bronchiectasis and the acute respiratory distress syndrome.
first_indexed 2024-03-08T00:08:47Z
format Article
id doaj.art-0b6e6acfca2f4e87b4dbc09bc0ef7656
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-03-08T00:08:47Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-0b6e6acfca2f4e87b4dbc09bc0ef76562024-02-17T06:42:02ZengElsevieriScience2589-00422024-03-01273108835Airway inflammation accelerates pulmonary exacerbations in cystic fibrosisTheodore G. Liou0Natalia Argel1Fadi Asfour2Perry S. Brown3Barbara A. Chatfield4David R. Cox5Cori L. Daines6Dixie Durham7Jessica A. Francis8Barbara Glover9My Helms10Theresa Heynekamp11John R. Hoidal12Judy L. Jensen13Christiana Kartsonaki14Ruth Keogh15Carol M. Kopecky16Noah Lechtzin17Yanping Li18Jerimiah Lysinger19Osmara Molina20Craig Nakamura21Kristyn A. Packer22Robert Paine, III23Katie R. Poch24Alexandra L. Quittner25Peggy Radford26Abby J. Redway27Scott D. Sagel28Rhonda D. Szczesniak29Shawna Sprandel30Jennifer L. Taylor-Cousar31Jane B. Vroom32Ryan Yoshikawa33John P. Clancy34J. Stuart Elborn35Kenneth N. Olivier36Frederick R. Adler37Adult Cystic Fibrosis Center, Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, 26 North Mario Capecchi Drive, Salt Lake City, UT 84132, USA; Primary Children’s Cystic Fibrosis Center, Division of Pediatric Pulmonology, Department of Pediatrics, University of Utah, 81 North Mario Capecchi Drive, Salt Lake City, UT 84113, USA; Corresponding authorCystic Fibrosis Center, Phoenix Children’s Hospital, 1919 East Thomas Road, Phoenix, AZ 85016, USAPrimary Children’s Cystic Fibrosis Center, Division of Pediatric Pulmonology, Department of Pediatrics, University of Utah, 81 North Mario Capecchi Drive, Salt Lake City, UT 84113, USASt. Luke’s Cystic Fibrosis Center of Idaho, 610 W. Hays Street, Boise, ID 83702, USAPrimary Children’s Cystic Fibrosis Center, Division of Pediatric Pulmonology, Department of Pediatrics, University of Utah, 81 North Mario Capecchi Drive, Salt Lake City, UT 84113, USANuffield College, 1 New Rd, Oxford OX1 1NF, UKDivision of Pediatric Pulmonary and Sleep Medicine, Department of Pediatrics, University of Arizona Health Sciences, University of Arizona, 1501 N. Campbell Avenue, Room 3301, PO Box 245073, Tucson, AZ 85724, USANuffield College, 1 New Rd, Oxford OX1 1NF, UKAdult Cystic Fibrosis Center, Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, 26 North Mario Capecchi Drive, Salt Lake City, UT 84132, USACystic Fibrosis Center, 3006 S. Maryland Pkwy, Suite #315, Las Vegas, NV 89109, USAAdult Cystic Fibrosis Center, Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, 26 North Mario Capecchi Drive, Salt Lake City, UT 84132, USAAdult Cystic Fibrosis Program, Division of Pulmonary, Critical Care and Sleep Medicine, DoIM MSC10-5550, 1 University of New Mexico, Albuquerque, NM 87131, USAAdult Cystic Fibrosis Center, Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, 26 North Mario Capecchi Drive, Salt Lake City, UT 84132, USAAdult Cystic Fibrosis Center, Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, 26 North Mario Capecchi Drive, Salt Lake City, UT 84132, USAClinical Trial Service Unit & Epidemiological Studies Unit and Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UKDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UKDepartment of Pediatrics, Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus, 13123 East 16th Avenue, Aurora, CO 80045, USADivision of Pulmonary and Critical Care and Sleep Medicine, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E. Monument Street, Baltimore, MD 21205, USAAdult Cystic Fibrosis Center, Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, 26 North Mario Capecchi Drive, Salt Lake City, UT 84132, USAMontana Cystic Fibrosis Center, Billings Clinic, 2800 10th Avenue N, Billings, MT 59101, USADivision of Pediatric Pulmonary and Sleep Medicine, Department of Pediatrics, University of Arizona Health Sciences, University of Arizona, 1501 N. Campbell Avenue, Room 3301, PO Box 245073, Tucson, AZ 85724, USACystic Fibrosis Center, 3006 S. Maryland Pkwy, Suite #315, Las Vegas, NV 89109, USAAdult Cystic Fibrosis Center, Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, 26 North Mario Capecchi Drive, Salt Lake City, UT 84132, USAAdult Cystic Fibrosis Center, Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, 26 North Mario Capecchi Drive, Salt Lake City, UT 84132, USADivision of Pulmonary and Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USABehavioral Health Systems Research, Miami, FL 33133, USACystic Fibrosis Center, Phoenix Children’s Hospital, 1919 East Thomas Road, Phoenix, AZ 85016, USAAdult Cystic Fibrosis Program, Division of Pulmonary, Critical Care and Sleep Medicine, DoIM MSC10-5550, 1 University of New Mexico, Albuquerque, NM 87131, USADepartment of Pediatrics, Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus, 13123 East 16th Avenue, Aurora, CO 80045, USADivision of Biostatistics & Epidemiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USAMontana Cystic Fibrosis Center, Billings Clinic, 2800 10th Avenue N, Billings, MT 59101, USADivision of Pulmonary and Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA; Division of Pulmonology, Department of Pediatrics, National Jewish Health, 1400 Jackson St, Denver, CO 80206, USAAdult Cystic Fibrosis Center, Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, 26 North Mario Capecchi Drive, Salt Lake City, UT 84132, USA; Primary Children’s Cystic Fibrosis Center, Division of Pediatric Pulmonology, Department of Pediatrics, University of Utah, 81 North Mario Capecchi Drive, Salt Lake City, UT 84113, USACystic Fibrosis Center, 3006 S. Maryland Pkwy, Suite #315, Las Vegas, NV 89109, USAFormer: Division of Pulmonary Medicine, Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USASchool of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Health Sciences Building, Lisburn Rd, Belfast BT9 7AE, UKLaboratory of Chronic Airway Infection, Pulmonary Branch, National Heart Lung and Blood Institute, National Institutes of Health, 10 Center Drive MSC1454, Building 10-CRC, Room 1408A, Bethesda, MD 20892, USADepartment of Mathematics, 155 South 1400 East, University of Utah, Salt Lake City, UT 84112, USA; School of Biological Sciences, 257 South 1400 East, University of Utah, Salt Lake City, UT 84112, USASummary: Airway inflammation underlies cystic fibrosis (CF) pulmonary exacerbations. In a prospective multicenter study of randomly selected, clinically stable adolescents and adults, we assessed relationships between 24 inflammation-associated molecules and the future occurrence of CF pulmonary exacerbation using proportional hazards models. We explored relationships for potential confounding or mediation by clinical factors and assessed sensitivities to treatments including CF transmembrane regulator (CFTR) protein synthesis modulators. Results from 114 participants, including seven on ivacaftor or lumacaftor-ivacaftor, representative of the US CF population during the study period, identified 10 biomarkers associated with future exacerbations mediated by percent predicted forced expiratory volume in 1 s. The findings were not sensitive to anti-inflammatory, antibiotic, and CFTR modulator treatments. The analyses suggest that combination treatments addressing RAGE-axis inflammation, protease-mediated injury, and oxidative stress might prevent pulmonary exacerbations. Our work may apply to other airway inflammatory diseases such as bronchiectasis and the acute respiratory distress syndrome.http://www.sciencedirect.com/science/article/pii/S2589004224000567Health sciencesMedicineMedical specialtyrespiratory medicineOmics
spellingShingle Theodore G. Liou
Natalia Argel
Fadi Asfour
Perry S. Brown
Barbara A. Chatfield
David R. Cox
Cori L. Daines
Dixie Durham
Jessica A. Francis
Barbara Glover
My Helms
Theresa Heynekamp
John R. Hoidal
Judy L. Jensen
Christiana Kartsonaki
Ruth Keogh
Carol M. Kopecky
Noah Lechtzin
Yanping Li
Jerimiah Lysinger
Osmara Molina
Craig Nakamura
Kristyn A. Packer
Robert Paine, III
Katie R. Poch
Alexandra L. Quittner
Peggy Radford
Abby J. Redway
Scott D. Sagel
Rhonda D. Szczesniak
Shawna Sprandel
Jennifer L. Taylor-Cousar
Jane B. Vroom
Ryan Yoshikawa
John P. Clancy
J. Stuart Elborn
Kenneth N. Olivier
Frederick R. Adler
Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
iScience
Health sciences
Medicine
Medical specialty
respiratory medicine
Omics
title Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
title_full Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
title_fullStr Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
title_full_unstemmed Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
title_short Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
title_sort airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
topic Health sciences
Medicine
Medical specialty
respiratory medicine
Omics
url http://www.sciencedirect.com/science/article/pii/S2589004224000567
work_keys_str_mv AT theodoregliou airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT nataliaargel airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT fadiasfour airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT perrysbrown airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT barbaraachatfield airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT davidrcox airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT corildaines airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT dixiedurham airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT jessicaafrancis airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT barbaraglover airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT myhelms airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT theresaheynekamp airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT johnrhoidal airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT judyljensen airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT christianakartsonaki airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT ruthkeogh airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT carolmkopecky airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT noahlechtzin airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT yanpingli airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT jerimiahlysinger airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT osmaramolina airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT craignakamura airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT kristynapacker airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT robertpaineiii airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT katierpoch airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT alexandralquittner airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT peggyradford airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT abbyjredway airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT scottdsagel airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT rhondadszczesniak airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT shawnasprandel airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT jenniferltaylorcousar airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT janebvroom airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT ryanyoshikawa airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT johnpclancy airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT jstuartelborn airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT kennethnolivier airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis
AT frederickradler airwayinflammationacceleratespulmonaryexacerbationsincysticfibrosis